779 related articles for article (PubMed ID: 28413031)
1. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
Chen Y; Peng W; Raffetto JD; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
[TBL] [Abstract][Full Text] [Related]
2. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.
MacColl E; Khalil RA
J Pharmacol Exp Ther; 2015 Dec; 355(3):410-28. PubMed ID: 26319699
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.
Kucukguven A; Khalil RA
Curr Drug Targets; 2013 Mar; 14(3):287-324. PubMed ID: 23316963
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.
Raffetto JD; Khalil RA
Vessel Plus; 2021; 5():. PubMed ID: 34250453
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of varicose vein formation: valve dysfunction and wall dilation.
Raffetto JD; Khalil RA
Phlebology; 2008; 23(2):85-98. PubMed ID: 18453484
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in venous tissue remodeling and varicose vein formation.
Raffetto JD; Khalil RA
Curr Vasc Pharmacol; 2008 Jul; 6(3):158-72. PubMed ID: 18673156
[TBL] [Abstract][Full Text] [Related]
9. Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins.
Raffetto JD; Qiao X; Koledova VV; Khalil RA
J Vasc Surg; 2008 Aug; 48(2):447-56. PubMed ID: 18502086
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
Raffetto JD; Khalil RA
Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
[TBL] [Abstract][Full Text] [Related]
11. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
12. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
13. Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall.
Hu X; Hu F; Xu Y; Tang J; Chu H; Zhong Y
Int Angiol; 2019 Jun; 38(3):185-193. PubMed ID: 31058480
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins.
Xu HM; Zhao Y; Zhang XM; Zhu T; Fu WG
J Surg Res; 2011 Jun; 168(1):e143-8. PubMed ID: 21195432
[TBL] [Abstract][Full Text] [Related]
15. MMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides.
Raffetto JD; Barros YV; Wells AK; Khalil RA
J Surg Res; 2010 Apr; 159(2):755-64. PubMed ID: 19482300
[TBL] [Abstract][Full Text] [Related]
16. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of primary varicose veins.
Lim CS; Davies AH
Br J Surg; 2009 Nov; 96(11):1231-42. PubMed ID: 19847861
[TBL] [Abstract][Full Text] [Related]
18. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration.
Nicolaides AN
Angiology; 2005; 56 Suppl 1():S11-9. PubMed ID: 16193221
[TBL] [Abstract][Full Text] [Related]
19. Sulodexide Improves Contraction and Decreases Matrix Metalloproteinase-2 and -9 in Veins Under Prolonged Stretch.
Raffetto JD; Yu W; Wang X; Calanni F; Mattana P; Khalil RA
J Cardiovasc Pharmacol; 2020 Mar; 75(3):211-221. PubMed ID: 31738197
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
